相关实验视频
Updated: Sep 16, 2025

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
Nup93-介导的RNA替代分离与糖尿病动脉样硬化相关
Xiaojing Yuan1, Qilun Zhang2, Jie Li3
1Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China; Department of Endocrinology and Laboratory for Diabetes, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
糖尿病通过破坏Nup93在血管光滑肌细胞 (VSMCs) 中加速动脉样硬化. 这损害了拼接因子的进口,导致异常的基因拼接,促进了VSMC的增殖,突出了糖尿病相关动脉样硬化的新治疗标.
科学领域:
- 心血管生物学 心血管生物学
- 代谢疾病 代谢疾病
- 分子医学是分子医学.
背景情况:
- 动脉样硬化是糖尿病的主要并发症,增加死亡风险.
- 血管光滑肌细胞 (VSMC) 是动脉样硬化斑块的关键组成部分.
- 目前的蛋白质组方法缺乏空间分辨率,缺少动脉样硬化中的细胞特异性变化.
研究的目的:
- 研究糖尿病促进动脉样硬化的机制.
- 为了确定治疗糖尿病相关动脉样硬化的分子标.
主要方法:
- 在动脉样硬化和DM的小鼠模型上的空间蛋白质组学.
- 在动脉样硬化和DM的细胞模型上进行RNA测序.
- 在糖尿病压力下的VSMC中分析蛋白质和RNA变化.
主要成果:
- 在VSMC中,高葡萄糖和ox-LDL降低了Nup93的表达.
- 减少Nup93损害了拼接因子SRSF1和SRSF3.3的核进口.
- 这导致了SerpinE2的异常替代拼接,增加了其mRNA稳定性并促进了VSMC的增殖.
结论:
- 一个新的机制将糖尿病压力,Nup93下调,拼接失调和动脉样硬化中的VSMC增殖联系在一起.
- Nup93介导的拼接调节是糖尿病相关动脉样硬化的潜在治疗标.
相关概念视频
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Editing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Experimental RNAi

